MedTrace Logo

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

NCT02102828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-04-10

No results posted yet for this study

Summary

The Cothera VPulse(tm) mechanical compression device (MCD) combines rapid intermittent sequential compression with cold therapy and is designed for single patient use in the home. Additionally, it can track patient compliance. This study will examine if there is a difference in deep vein thrombosis (DVT) occurrence over 3 weeks after tourniquet-less total knee arthroplasty (TKA) and multimodal prophylaxis with or without extended MCD use in a cooling device/MCD system.

Conditions

  • Deep Vein Thrombosis

Interventions

DEVICE

extended compression

Home use of extended compression therapy and aspirin

OTHER

Aspirin

standard therapy of aspirin

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Principal Investigators

  • Mark A Snyder, MD · TriHealth Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102828 on ClinicalTrials.gov